- Home
- BLND vs IRMD Comparison
BLND vs IRMD Comparison
Compare BLND & IRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLND
- IRMD
- Stock Information
- Founded
- BLND 2012
- IRMD 1992
- Country
- BLND United States
- IRMD United States
- Employees
- BLND N/A
- IRMD N/A
- Industry
- BLND EDP Services
- IRMD Medical/Dental Instruments
- Sector
- BLND Technology
- IRMD Health Care
- Exchange
- BLND Nasdaq
- IRMD Nasdaq
- Market Cap
- BLND 815.3M
- IRMD 662.5M
- IPO Year
- BLND 2021
- IRMD 2014
- Fundamental
- Price
- BLND $3.19
- IRMD $53.05
- Analyst Decision
- BLND Buy
- IRMD Strong Buy
- Analyst Count
- BLND 8
- IRMD 1
- Target Price
- BLND $4.45
- IRMD $72.00
- AVG Volume (30 Days)
- BLND 3.4M
- IRMD 37.5K
- Earning Date
- BLND 05-08-2025
- IRMD 05-05-2025
- Dividend Yield
- BLND N/A
- IRMD 1.29%
- EPS Growth
- BLND N/A
- IRMD 11.11
- EPS
- BLND N/A
- IRMD 1.50
- Revenue
- BLND $162,019,000.00
- IRMD $73,242,121.00
- Revenue This Year
- BLND $15.07
- IRMD $10.58
- Revenue Next Year
- BLND $21.95
- IRMD $17.74
- P/E Ratio
- BLND N/A
- IRMD $35.15
- Revenue Growth
- BLND 3.30
- IRMD 11.71
- 52 Week Low
- BLND $2.08
- IRMD $40.55
- 52 Week High
- BLND $5.53
- IRMD $63.29
- Technical
- Relative Strength Index (RSI)
- BLND 44.58
- IRMD 55.33
- Support Level
- BLND $2.97
- IRMD $50.14
- Resistance Level
- BLND $3.18
- IRMD $52.44
- Average True Range (ATR)
- BLND 0.23
- IRMD 2.38
- MACD
- BLND -0.01
- IRMD 0.29
- Stochastic Oscillator
- BLND 36.18
- IRMD 100.00
About BLND Blend Labs Inc.
Blend Labs Inc is a cloud-based platform software platform that powers the digital interface between financial services firms and consumers. It supports and simplifies applications for mortgages, consumer loans, and deposit accounts. Its operating segments are; Blend Platform segment which comprises a suite of products that power the entire origination process from back-end workflows to consumer experience, and the Title segment enables customers to streamline the title, settlement, and closing process at scale for mortgages, home equity lines of credit, and home equity loans. The majority of the revenue for the company is generated from the Blend Platform segment.
About IRMD iRadimed Corporation
iRadimed Corp develops, manufactures, markets and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates majority revenue from United States.